Form 4 for CRBP Corbus Pharmaceuticals Holdings, Inc.
Accepted 2024-01-30 00:00:00 ET · period of report 2024-01-26 · accession 0001209191-24-002449 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-30 | 2024-01-26 | CRBP | HOLMER ALAN F | Dir | M - OptEx | $4.97 | +629 | 1,379 | +84% | +$3,126 |
| D | 2024-01-30 | 2024-01-26 | CRBP | HOLMER ALAN F | Dir | M - OptEx | $4.97 | -629 | 0 | -100% | -$3,126 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-26 | M | A | 629 | $4.97 | 1,379 | D | — | — | |
| 2 | Derivative | Options to purchase common stock | 2024-01-26 | M | D | 629 | $4.97 | 0 | D | $4.97 · 2014-02-28 to 2024-01-29 | 629 Common stock | (F1) The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option vested in equal monthly installments over a period of 12 months commencing on February 28, 2014. |